BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients
Completed
- Conditions
- Magnetic Resonance ImagingMagnetic Resonance Angiography
- Interventions
- First Posted Date
- 2010-03-29
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 23775
- Registration Number
- NCT01095081
NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)
Phase 4
Terminated
- Conditions
- Hypogonadism
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-03-25
- Last Posted Date
- 2014-11-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 4
- Registration Number
- NCT01092858
MiCo - Mirena or Conventional Medical Treatment for Menorrhagia
Completed
- Conditions
- Idiopathic Menorrhagia
- Interventions
- First Posted Date
- 2010-03-12
- Last Posted Date
- 2012-04-10
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1211
- Registration Number
- NCT01085487
Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites
Phase 1
Completed
- Conditions
- Contraception
- Interventions
- Drug: Gestodene/EE Patch (BAY86-5016)
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2014-06-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 43
- Registration Number
- NCT01083264
Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- Drug: Acetylsalicylic Acid (Aspirin BAY1019036)Drug: Alka Seltzer Extra Strength
- First Posted Date
- 2010-03-05
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 26
- Registration Number
- NCT01081353
Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2015-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 73
- Registration Number
- NCT01076595
Comparative Trial in Hormone Withdrawal Associated Symptoms
Phase 3
Completed
- Conditions
- Oral Contraceptive
- Interventions
- Drug: EE20/DRSP (YAZ, BAY86-5300)
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2014-10-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 592
- Registration Number
- NCT01076582
Pharmacodynamic Study Comparing the Effects of Two Different Forms of Omeprazole (P07812) (COMPLETED)
Phase 3
Completed
- Conditions
- Intragastric Acidity
- Interventions
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 30
- Registration Number
- NCT01077076
Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy Adults
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 24
- Registration Number
- NCT01073891
Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension
Phase 1
Completed
- Conditions
- Anti-Infective Agents
- Interventions
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2014-04-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 26
- Registration Number
- NCT01073540